TRPM2 was also identified in the foci of human breast cancers (MDA-MB-231 and MCF-7 cells), and inhibition with 2-APB, or silencing through RNAi, reduced tumor cell multiplication (191; Table 1). Here, TRPM2 is linked to neoplasm.